Since the emergence of the coronavirus disease 19 (COVID-19), a number of studies have reported the presence of cardiovascular diseases in affected patients and linked them with a higher risk of mortality. We conducted an online search in Medline/PubMed to identify original cohorts comparing data between survivors and non-survivors from COVID-19. The presence of cardiovascular events and related biomarkers were compared between the 2 groups. Data on 1,845 hospitalized patients with COVID-19 were pooled from 12 comparative studies. The overall mortality rate in relation to COVID-19 was 17.6%. Men aged > 50 years old were more likely to die from COVID-19. Significant co-morbidities contributing to mortality were hypertension, diabetes mellitus, smoking, a previous history of cardiovascular disease including chronic heart failure, and cerebrovascular accidents. A significant relationship was observed between mortality and patient presentation with dyspnea, fatigue, tachycardia, and hypoxemia. Cardiovascular disease-related laboratory biomarkers related to mortality were elevated serum level of lactate dehydrogenase, creatine kinase, brain natriuretic peptide, and cardiac troponin I. Adverse cardiovascular disease-related clinical events preceding death were shock, arrhythmias, and acute myocardial injury. In conclusion, severe clinical presentation and elevated biomarkers in COVID-19 patients with established risk factors can predict mortality from cardiovascular causes.
【초록키워드】 COVID-19, coronavirus disease, Biomarker, Mortality, fatigue, Diabetes Mellitus, peptide, cardiovascular disease, smoking, risk factor, hypertension, lactate dehydrogenase, Brain, cardiovascular, cardiac troponin, Cohort, Shock, myocardial injury, Hypoxemia, Dyspnea, Patient, death, co-morbidity, Arrhythmias, predict, COVID-19 patient, Tachycardia, Adverse, higher risk, Serum level, overall mortality, causes, survivor, event, cerebrovascular accidents, non-survivor, chronic heart failure, identify, affected, reported, elevated, conducted, hospitalized patient, contributing to, groups, Significant, cardiovascular event, laboratory biomarker, with COVID-19, 【제목키워드】 COVID-19, cardiovascular,